substance p has been researched along with Elevated Cholesterol in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 7 (63.64) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Herrmann, J; Lerman, A; Lerman, LO; Napoli, C; Rodriguez-Porcel, M; Sawamura, T | 1 |
| Arden, WA; Chein, S; Gross, DR; Maley, RH; Salley, RK; Vrettos, AM | 1 |
| Cannon, RO; Casino, PR; Kilcoyne, CM; Panza, JA; Quyyumi, AA | 1 |
| Doi, H; Kugiyama, K; Matsumura, T; Ohta, Y; Sugiyama, S; Yasue, H | 1 |
| Andrews, NP; Cannon, RO; Husain, S; Mulcahy, D; Panza, JA; Quyyumi, AA | 1 |
| Chin-Dusting, JP; Cooper, BA; Dart, AM; Lewis, TV | 1 |
| Cooper, A; Heagerty, AM | 1 |
| Aikawa, K; Maehara, K; Maruyama, Y; Ohtake, A; Ohwada, T; Onogi, F; Saito, T; Saitoh, S | 1 |
| Tiefenbacher, CP | 1 |
| Bloomfield, P; Boon, NA; Fox, KA; Ludlam, CA; Newby, DE; Webb, DJ; Witherow, FN; Wright, RA | 1 |
| Cohen, RA; Cunningham, LD; Haudenschild, CC; Zitnay, KM | 1 |
1 trial(s) available for substance p and Elevated Cholesterol
| Article | Year |
|---|---|
Hypercholesterolaemia and lipid lowering treatment do not affect the acute endogenous fibrinolytic capacity in vivo.
Topics: Adult; Anticholesteremic Agents; Blood Flow Velocity; Blood Pressure; Case-Control Studies; Cross-Over Studies; Double-Blind Method; Female; Fibrinolysis; Forearm; Humans; Hypercholesterolemia; Male; Pravastatin; Substance P; Tissue Plasminogen Activator | 2002 |
10 other study(ies) available for substance p and Elevated Cholesterol
| Article | Year |
|---|---|
Hypercholesterolemia and hypertension have synergistic deleterious effects on coronary endothelial function.
Topics: Animals; Antioxidants; Ascorbic Acid; Bradykinin; Calcimycin; Coronary Artery Disease; Coronary Vessels; Cyclic GMP; Diet, Atherogenic; Endothelin-1; Endothelium, Vascular; Female; Hemodynamics; Hypercholesterolemia; Hypertension, Renovascular; Lipids; Nitric Oxide; Nitroprusside; Oxidative Stress; Renal Artery Obstruction; Renin; Substance P; Swine; Vasodilator Agents; Vitamin E | 2003 |
Coronary vascular and myocardial effects of substance P in hypercholesterolemic rabbits.
Topics: Animals; Cholesterol, Dietary; Coronary Vessels; Heart; Hypercholesterolemia; Injections, Intra-Arterial; Male; Rabbits; Substance P; Vasoconstrictor Agents | 1994 |
Impaired endothelium-dependent vascular relaxation in patients with hypercholesterolemia extends beyond the muscarinic receptor.
Topics: Acetylcholine; Adult; Aged; Cholesterol; Endothelium, Vascular; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Nitroprusside; Receptors, Muscarinic; Substance P; Vasodilation | 1995 |
Suppression of atherosclerotic changes in cholesterol-fed rabbits treated with an oral inhibitor of neutral endopeptidase 24.11 (EC 3.4.24.11).
Topics: Administration, Oral; Animals; Aorta, Thoracic; Arteriosclerosis; Atrial Natriuretic Factor; Body Weight; Cholesterol, Dietary; Diet, Atherogenic; Drug Evaluation, Preclinical; Enzyme Inhibitors; Glycopeptides; Hemodynamics; Hypercholesterolemia; Indans; Lipids; Male; Natriuretic Peptide, C-Type; Neprilysin; Nitroprusside; Organ Culture Techniques; Propionates; Proteins; Rabbits; Substance P; Vasodilation | 1996 |
Coronary vascular nitric oxide activity in hypertension and hypercholesterolemia. Comparison of acetylcholine and substance P.
Topics: Acetylcholine; Adult; Coronary Circulation; Coronary Vessels; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; Humans; Hypercholesterolemia; Hypertension; Male; Middle Aged; Nitric Oxide; Nitroprusside; omega-N-Methylarginine; Reference Values; Substance P; Vascular Resistance; Vasodilation | 1997 |
Responses to endothelium-dependent agonists in subcutaneous arteries excised from hypercholesterolaemic men.
Topics: Acetylcholine; Arteries; Cholesterol, HDL; Cholesterol, LDL; Endothelium, Vascular; Humans; Hypercholesterolemia; Male; Nitroprusside; Norepinephrine; Substance P; Vasoconstrictor Agents; Vasodilator Agents | 1998 |
Endothelial dysfunction in human intramyocardial small arteries in atherosclerosis and hypercholesterolemia.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Adult; Arteries; Arteriosclerosis; Bradykinin; Cardiomyopathies; Coronary Circulation; Endothelium, Vascular; Female; Heart; Heart Failure; Heart Transplantation; Humans; Hypercholesterolemia; In Vitro Techniques; Isometric Contraction; Male; Middle Aged; Nitroprusside; Substance P; Vasodilation | 1998 |
Morphological and functional changes in coronary vessel evoked by repeated endothelial injury in pigs.
Topics: Acetylcholine; Animals; Coronary Vessels; Endothelium, Vascular; Enzyme Inhibitors; Hypercholesterolemia; Isosorbide Dinitrate; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Regeneration; Serotonin; Substance P; Swine; Vasoconstrictor Agents; Vasodilator Agents | 1998 |
Tetrahydrobiopterin: a critical cofactor for eNOS and a strategy in the treatment of endothelial dysfunction?
Topics: Animals; Arginine; Biopterins; Cardiovascular Diseases; Clinical Trials as Topic; Coronary Vessels; Dogs; Endothelium, Vascular; Enzyme Inhibitors; Histamine; Humans; Hypercholesterolemia; In Vitro Techniques; Infusions, Intra-Arterial; Ionophores; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Pteridines; Pterins; Reactive Oxygen Species; Species Specificity; Substance P; Swine; Vasoconstrictor Agents; Vasodilator Agents | 2001 |
Loss of selective endothelial cell vasoactive functions caused by hypercholesterolemia in pig coronary arteries.
Topics: Animals; Calcimycin; Coronary Vessels; Dinoprost; Endothelium, Vascular; Hypercholesterolemia; Nitroprusside; Norepinephrine; Papaverine; Potassium; Serotonin; Substance P; Swine; Vasoconstriction | 1988 |